At its present level of around $200, WST stock is trading at just 5.1x trailing revenue, compared to its five-year average ...
West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of ...
West Pharmaceuticals stock drops 38% after ending glucose monitor contracts; CEO Eric Green says GLP-1 business will offset ...
BofA lowered the firm’s price target on West Pharmaceutical (WST) to $285 from $355 and keeps a Buy rating on the shares after the company ...
West Pharmaceutical Services stock sank Thursday after the company issued a full-year outlook that missed analysts’ expectations. Shares plunged 31% to $222.46, putting them on pace for their worst ...
Deutsche Bank upgraded West Pharmaceutical Services (NYSE:WST) to Buy from Hold on Friday, even after the contract drug manufacturer witnessed a ~38% drop in the previous session following a ...